Does the Medicare GLP-1 Bridge cover Wegovy for sleep apnea?

No. The Bridge program's qualifying conditions list does not include sleep apnea. To access the $50 Bridge copay, you need a qualifying condition like uncontrolled hypertension, heart failure, chronic kidney disease, prior heart attack or stroke, prediabetes, or peripheral artery disease.

Can I get Wegovy through Medicare if I have sleep apnea?

Possibly, through three paths: (1) qualify through another Bridge condition like hypertension or prediabetes, (2) check whether your specific Part D plan covers Wegovy for sleep apnea outside the Bridge, or (3) apply for Novo Nordisk's patient assistance program if you have limited income.

Does Medicare cover CPAP for sleep apnea?

Yes. CPAP machines are well-covered under Medicare Part B as durable medical equipment. CPAP remains the standard first-line treatment for sleep apnea. Wegovy is often used as a complementary treatment for patients with obesity, not as a replacement for CPAP.

How do I find out if my Part D plan covers Wegovy for sleep apnea?

Call your Part D plan directly and ask: 'Does my plan cover Wegovy for obstructive sleep apnea with prior authorization?' Coverage varies significantly between plans. Have your sleep study results and BMI ready when you call.

Does Medicare Cover Wegovy for Sleep Apnea?

Q: Is Wegovy FDA-approved for sleep apnea?

Yes. In December 2024, the FDA approved Wegovy as the first medication specifically indicated for moderate-to-severe obstructive sleep apnea in adults with obesity. The approval was based on the SURMOUNT-OSA trial showing significant reduction in apnea severity.

The Short Answer

Wegovy is FDA-approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity (approved December 2024). However, Medicare's GLP-1 Bridge program does not include sleep apnea as a qualifying condition for the $50 copay. This catches many seniors off guard — the drug works for sleep apnea, but Medicare's specific weight-loss coverage program does not list sleep apnea on its qualifying-conditions list.

That does not mean you have no options. This guide explains exactly where coverage stands, what your alternatives are, and what to discuss with your doctor.

What the FDA Approval Says

In December 2024, the FDA approved Wegovy (semaglutide 2.4mg) as the first medication specifically indicated for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. The approval was based on the SURMOUNT-OSA clinical trial, which showed Wegovy reduced sleep apnea severity (measured by AHI — apnea-hypopnea index) by an average of 50-60% when combined with weight loss.

This is a real medical use. Wegovy is now a recognized treatment for OSA — not just weight loss.

Why Medicare's Bridge Does Not Cover It for Sleep Apnea

The Medicare GLP-1 Bridge is a weight-management program. CMS defined a specific list of qualifying conditions when designing the demonstration:

Tier 1 (BMI 35+): No additional condition required
Tier 2 (BMI 30+): Heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease (stage 3a+)
Tier 3 (BMI 27+): Prediabetes, prior heart attack, prior stroke, or symptomatic peripheral artery disease

Sleep apnea is not on any tier's qualifying list. Neither is type 2 diabetes, high cholesterol, or osteoarthritis — even though all of these can be related to obesity.

This is a design choice by CMS, not a clinical judgment. The Bridge was scoped to cardiovascular and metabolic conditions where the evidence for weight-loss benefit is strongest.

So How Can You Get Coverage?

You have three realistic paths:

Path 1: Qualify Through Another Condition

Many seniors with sleep apnea also have one of the Bridge-qualifying conditions. Specifically:

High blood pressure that is not controlled on two or more medications (Tier 2)
Prior heart attack or stroke (Tier 3)
Prediabetes (Tier 3) — common in adults with sleep apnea
Chronic kidney disease stage 3a+ (Tier 2)

If you have sleep apnea AND any of these qualifying conditions, your doctor can submit the prior authorization based on the qualifying condition. Sleep apnea would be a secondary benefit, not the basis for coverage.

Take our 2-minute eligibility quiz to check whether you qualify through any of these paths.

Path 2: Try Standard Part D Coverage

Some Medicare Part D plans cover Wegovy specifically for sleep apnea — outside the Bridge — based on the FDA's sleep apnea indication. This is not standardized across plans, and coverage requires:

A confirmed sleep apnea diagnosis (with sleep study results)
BMI in the obesity range (typically 30+)
A prior authorization submitted to your specific Part D plan (not CMS)

This is where it gets complicated. Each Part D plan handles this differently. Some cover it, some do not, and the copay can be much higher than the $50 Bridge rate. Call your Part D plan directly and ask: "Does my plan cover Wegovy for obstructive sleep apnea with prior authorization?"

Path 3: Manufacturer Patient Assistance

Novo Nordisk (Wegovy's manufacturer) offers a Patient Assistance Program (NovoCare) for patients who cannot afford the medication. Eligibility is income-based. For most Medicare beneficiaries with limited income, this can provide Wegovy at significantly reduced or no cost — but only if other coverage options fail.

Visit novocare.com or call 1-866-310-7549 to check eligibility.

What About CPAP?

CPAP machines remain the gold standard treatment for sleep apnea and are well-covered under Medicare Part B (durable medical equipment), not Part D. If you have not already tried CPAP, your doctor will likely recommend it first — both because of the strong coverage and because CPAP works immediately without weight-loss prerequisites.

Wegovy's role in sleep apnea is generally as a complementary treatment for patients with obesity, often used alongside CPAP rather than replacing it.

What to Ask Your Doctor

Bring these specific questions to your appointment:

"Do I qualify for the Medicare GLP-1 Bridge based on my other conditions?"
"If not, does my specific Part D plan cover Wegovy for sleep apnea with a prior authorization?"
"What is my AHI (apnea-hypopnea index) and BMI — do I meet the FDA criteria for Wegovy for OSA?"
"Am I a candidate for both CPAP and Wegovy together?"

For the full prior authorization process and what to bring to your appointment, see our Medicare & GLP-1 guide.

The Bottom Line

Wegovy can treat sleep apnea, and the FDA approves it for that use. But Medicare's $50 Bridge copay specifically excludes sleep apnea as a qualifying condition — you need a Tier 1, 2, or 3 condition to access the Bridge price. Many seniors with sleep apnea qualify through another condition; others may get coverage through their specific Part D plan or through manufacturer assistance.

Find a Prescriber

Use our Provider Directory to find Medicare-friendly doctors in your state who prescribe GLP-1 medications and handle the prior authorization process.

Track Your Progress

Already on a GLP-1? Use the free CairnSpace tracker to log your daily protein, hydration, symptoms, and weight — built specifically for people on GLP-1 medications. No sign-up fees, no ads.